Rights and permissions
About this article
Cite this article
Omalizumab confers significant QOL benefit in allergic asthma. Pharmacoecon. Outcomes News 393, 10 (2002). https://doi.org/10.1007/BF03280006
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280006